Concord Medical Files Annual Report on Form 20-F for Fiscal 2024
BEIJING, April 26, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced...
Zepp Health Corporation Files 2024 Annual Report on Form 20-F
MILPITAS, Calif., April 26, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it has filed its annual report on Form 20-F for...
Amcor to report fiscal 2025 third quarter results
ZURICH, April 26, 2025 /PRNewswire/ -- Amcor plc ("Amcor") (NYSE: AMCR, ASX: AMC) will announce its fiscal 2025 third quarter results for the three month period ended March 31, 2025, after the U.S. market closes on Wed., April 30, 2025. Amcor will...
Webull Files Annual Report on Form 20-F for Year Ended December 31, 2024
ST. PETERSBURG, Fla., April 26, 2025 /PRNewswire/ -- Webull Corporation (NASDAQ: BULL) today announced the filing of its annual report on Form 20-F for the fiscal year that ended on December 31, 2024, with the U.S. Securities and Exchange Commission...
MDJM LTD Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel
LETHAM, Scotland, April 26, 2025 /PRNewswire/ -- MDJM LTD (Nasdaq: UOKA) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, today announced that the Company received a staff determination letter (the "Letter"),...
BLUETTI Apex 300 and Full Ecosystem In-Person Debut at Media Day: Innovation Meets Sustainability
SHENZHEN, China, April 26, 2025 /PRNewswire/ -- Global clean energy leader BLUETTI , unveiled for the first time the complete Intelligent Ecosystem built around its new flagship—the Apex 300 , a sustainable and versatile power station. The debut...
Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab
HONG KONG, April 26, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has received approval from the National Medical Products...
Vivienne Westwood dazzles at Barcelona Bridal Night with an epic show
In the cloister of the historic building of the University of Barcelona BARCELONA, Spain, April 26, 2025 /PRNewswire/ -- The British brand Vivienne Westwood was the star of the Barcelona Bridal Night, held last night as part of the Barcelona Bridal...